Literature DB >> 33188637

Modulation of the Gut Microbiome and Obesity Biomarkers by Lactobacillus Plantarum KC28 in a Diet-Induced Obesity Murine Model.

Eunchong Huang1, Seulki Kim2, Haryung Park1,3, Soyoung Park1,3, Yosep Ji1,3, Svetoslav Dimitrov Todorov1, Sang-Dong Lim2, Wilhelm Heinrich Holzapfel4,5.   

Abstract

Lactobacillus plantarum KC28 showed a beneficial (anti-obesity) effect in a diet-induced obese (DIO) C57BL/6 murine model receiving an intermediate high-fat diet (IF). This diet was selected for probiotic studies by prior comparisons of different combinations of basic (carbohydrate, protein and fat) components for optimized induction of dietary obesity in a murine model. Prior selection of Lact. plantarum strain KC28 was based on different physiological tests for safety and functionality including cell line adhesion and anti-adipogenic activity. The strain was administered at 5.0 × 109 CFU/mouse/day to the DIO mice (control mice received a normal diet). The anti-obesity effect of KC28 and the well-known probiotic strains Lact. rhamnosus GG (LGG) and Lact. plantarum 299v was assessed over 12 weeks. Xenical served as anti-obesity control. The high-fat diet groups receiving strains KC28 and LGG and the control Xenical group showed significant weight loss and notable changes in some obesity-related biomarkers in the liver (significant up-regulation of PGC1-α and CPT1-α only by KC28; p < 0.05) and mesenteric adipose tissue (significant down-regulation of ACOX-1, PPAR-γ, and FAS; KC28 p < 0.001 for PPAR-γ and FAS), compared with the IF control. Favourable changes in the studied biomarkers suggest a similar beneficial influence of Lact. plantarum KC28 on the alleviation of obesity comparable with that of the two well-studied probiotic strains, LGG and 299v. This probably resulted from a modulation in the cecal microbiota of the IF group by either probiotic strain, yet in a different manner, showing a highly significant increase in the families Desulfovibrionaceae and Lactobacillaceae only in the group receiving Lact. plantarum KC28.

Entities:  

Keywords:  Adipose tissue; Anti-obesity effect; Gut microbiome; Lactobacillus plantarum; Murine model

Mesh:

Substances:

Year:  2020        PMID: 33188637     DOI: 10.1007/s12602-020-09720-0

Source DB:  PubMed          Journal:  Probiotics Antimicrob Proteins        ISSN: 1867-1306            Impact factor:   4.609


  43 in total

1.  Evaluation of new broth media for microdilution antibiotic susceptibility testing of Lactobacilli, Pediococci, Lactococci, and Bifidobacteria.

Authors:  Ingo Klare; Carola Konstabel; Sibylle Müller-Bertling; Rolf Reissbrodt; Geert Huys; Marc Vancanneyt; Jean Swings; Herman Goossens; Wolfgang Witte
Journal:  Appl Environ Microbiol       Date:  2005-12       Impact factor: 4.792

Review 2.  Neurological consequences of obesity.

Authors:  Phillipe D O'Brien; Lucy M Hinder; Brian C Callaghan; Eva L Feldman
Journal:  Lancet Neurol       Date:  2017-06       Impact factor: 44.182

3.  Factors to consider when selecting a culture of Lactobacillus acidophilus as a dietary adjunct to produce a hypocholesterolemic effect in humans.

Authors:  S E Gilliland; D K Walker
Journal:  J Dairy Sci       Date:  1990-04       Impact factor: 4.034

4.  Modulation of the murine microbiome with a concomitant anti-obesity effect by Lactobacillus rhamnosus GG and Lactobacillus sakei NR28.

Authors:  Y S Ji; H N Kim; H J Park; J E Lee; S Y Yeo; J S Yang; S Y Park; H S Yoon; G S Cho; C M A P Franz; A Bomba; H K Shin; W H Holzapfel
Journal:  Benef Microbes       Date:  2012-03-01       Impact factor: 4.205

5.  Lactobacillus plantarum HAC01 regulates gut microbiota and adipose tissue accumulation in a diet-induced obesity murine model.

Authors:  Soyoung Park; Yosep Ji; Hoe-Yune Jung; Hyunjoon Park; Jihee Kang; Sang-Haeng Choi; Heuynkil Shin; Chang-Kee Hyun; Kyong-Tai Kim; Wilhelm H Holzapfel
Journal:  Appl Microbiol Biotechnol       Date:  2016-11-17       Impact factor: 4.813

6.  Probiotic strains of lactobacilli and bifidobacteria alter pro- and anti-inflammatory cytokines production in rats with monosodium glutamate-induced obesity.

Authors:  T M Falalyeyeva; I V Leschenko; T V Beregova; L M Lazarenko; O M Savchuk; L M Sichel; O I Tsyryuk; T B Vovk; M Ya Spivak
Journal:  Fiziol Zh       Date:  2017

7.  Anti-obesity effect of Lactobacillus rhamnosus LS-8 and Lactobacillus crustorum MN047 on high-fat and high-fructose diet mice base on inflammatory response alleviation and gut microbiota regulation.

Authors:  Tao Wang; Hong Yan; Yingying Lu; Xin Li; Xin Wang; Yuanyuan Shan; Yanglei Yi; Bianfang Liu; Yuan Zhou; Xin Lü
Journal:  Eur J Nutr       Date:  2019-10-28       Impact factor: 5.614

Review 8.  A Crosstalk Between Brain Cholesterol Oxidation and Glucose Metabolism in Alzheimer's Disease.

Authors:  Paola Gamba; Erica Staurenghi; Gabriella Testa; Serena Giannelli; Barbara Sottero; Gabriella Leonarduzzi
Journal:  Front Neurosci       Date:  2019-05-31       Impact factor: 4.677

Review 9.  Impact of the gut microbiota on inflammation, obesity, and metabolic disease.

Authors:  Claire L Boulangé; Ana Luisa Neves; Julien Chilloux; Jeremy K Nicholson; Marc-Emmanuel Dumas
Journal:  Genome Med       Date:  2016-04-20       Impact factor: 11.117

10.  Lactobacillus plantarum LMT1-48 exerts anti-obesity effect in high-fat diet-induced obese mice by regulating expression of lipogenic genes.

Authors:  Woo Jin Choi; Hye Jin Dong; Hyun Uk Jeong; Dong Wook Ryu; Soo Min Song; Yu Ri Kim; Hyun Ho Jung; Tai Hoon Kim; Yeung-Hyen Kim
Journal:  Sci Rep       Date:  2020-01-21       Impact factor: 4.379

View more
  1 in total

1.  Metabolomic Characteristics of Liver and Cecum Contents in High-Fat-Diet-Induced Obese Mice Intervened with Lactobacillus plantarum FRT10.

Authors:  Hongying Cai; Daojie Li; Liye Song; Xin Xu; Yunsheng Han; Kun Meng; Zhiguo Wen; Peilong Yang
Journal:  Foods       Date:  2022-08-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.